Werkstudent Personalmanagement (m/w/d)
Teilzeit, ab sofort
Verantwortliche Elektrofachkraft (m/w/d)
Minijob, unbefristet ab dem 01.04.2025
Mitarbeiter für Produktion & Inbetriebnahme (m/w/d)
Vollzeit, unbefristet, ab sofort
AB-CT is a pioneering medical technology company in the field of quality diagnostic breast imaging solutions.
Our breast CT scanner nu:view supports radiologists make reliable diagnoses, and has been specifically developed with the highest level of patient comfort in mind.
AB-CT was established in 2016 as a spin-off of the Institute of Medical Physics at the University of Erlangen (FAU) headed by Prof. Willi A. Kalender. Today, the AB-CT team of 50, continues the ground-breaking research and development of world-class solutions for diagnostic breast imaging for women.
There is a general consensus that 3D imaging with high level isotropic resolution will offer significant advantages. With nu:view, our expert team of genius software engineers, design engineers and medical physicists did not just develop another CT device, but a disruptive technology – Made in Germany.
Our goal is to empower radiologists all over the world to diagnose breast cancer early as this is the cure.
CEO
CTO
CINO
CMO
Founder and scientific advisor Willi A. Kalender has dedicated his professional life to research, mainly in the area of diagnostic imaging. The development and introduction of volumetric spiral computed tomography was a particular focus of his work.
In 2008, Prof. Kalender headed the project “Breast CT”, which was backed by the EU and the German Federal Ministry for Education and Research (BMBF).
AB-CT – Advanced Breast-CT GmbH
Henkestrasse 91
91052 Erlangen
Germany
Phone: +49 9131 97310 0
Fax: +49 9131 97310 10
E-Mail: info [at] ab-ct.com
You are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information